The charts on this page feature a breakdown of the total annual pay for the top executives at LABORATORY CORP OF AMERICA HOLDINGS as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. LABORATORY CORP OF AMERICA HOLDINGS income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. LABORATORY CORP OF AMERICA HOLDINGS annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Adam H. Schechter
Chief Executive Officer
Total Cash $5,079,449 Equity $15,040,149 Other $432,007 Total Compensation $20,551,605
Glenn A. Eisenberg
Executive Vice President Chief Financial Officer
Total Cash $2,256,982 Equity $4,158,050 Other $43,676 Total Compensation $6,458,708
MARK S. SCHROEDER
Executive Vice President, Diagnostics, Laboratory Operations and Global Supply Chain
Total Cash $1,556,409 Equity $2,398,369 Other $35,851 Total Compensation $3,990,629
BRIAN J. CAVENEY
Executive Vice President, Diagnostics Chief Medical Officer
Total Cash $1,556,409 Equity $2,398,369 Other $15,851 Total Compensation $3,970,629
PAUL R. KIRCHGRABER
Executive Vice President, Chief Executive Officer, Drug Development
Total Cash $1,867,690 Equity $2,398,369 Other $155,367 Total Compensation $4,421,426
For its 2021 fiscal year, LABORATORY CORP OF AMERICA HOLDINGS, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Adam H. Schechter CEO Pay $20,573,308 Median Employee Pay $57,614 CEO Pay Ratio 357:1
For its 2021 fiscal year, LABORATORY CORP OF AMERICA HOLDINGS, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
D. Gary Gilliland Total Cash $289,944
Garheng Kong Total Cash $309,944
Jean-Luc Bélingard Total Cash $289,944
Jeffrey A. Davis Total Cash $289,944
Kathryn E. Wengel Total Cash $234,472
Kerrii B. Anderson Total Cash $314,944
Peter M. Neupert Total Cash $349,944
R. Sanders Williams Total Cash $304,944
Richelle P. Parham Total Cash $289,944

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.